JP2001516732A5 - - Google Patents

Download PDF

Info

Publication number
JP2001516732A5
JP2001516732A5 JP2000511728A JP2000511728A JP2001516732A5 JP 2001516732 A5 JP2001516732 A5 JP 2001516732A5 JP 2000511728 A JP2000511728 A JP 2000511728A JP 2000511728 A JP2000511728 A JP 2000511728A JP 2001516732 A5 JP2001516732 A5 JP 2001516732A5
Authority
JP
Japan
Prior art keywords
carbon atoms
straight
group
chain
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000511728A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001516732A (ja
Filing date
Publication date
Priority claimed from DE19832159A external-priority patent/DE19832159A1/de
Application filed filed Critical
Priority claimed from PCT/EP1998/005874 external-priority patent/WO1999014174A1/de
Publication of JP2001516732A publication Critical patent/JP2001516732A/ja
Publication of JP2001516732A5 publication Critical patent/JP2001516732A5/ja
Pending legal-status Critical Current

Links

JP2000511728A 1997-09-18 1998-09-16 置換テトラヒドロナフタリンおよび類似化合物 Pending JP2001516732A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19741050 1997-09-18
DE19832159.7 1998-07-17
DE19832159A DE19832159A1 (de) 1997-09-18 1998-07-17 Substituierte Tetrahydro-naphthaline
DE19741050.2 1998-07-17
PCT/EP1998/005874 WO1999014174A1 (de) 1997-09-18 1998-09-16 Substituierte tetrahydro-naphtaline und analoge verbindungen

Publications (2)

Publication Number Publication Date
JP2001516732A JP2001516732A (ja) 2001-10-02
JP2001516732A5 true JP2001516732A5 (enExample) 2006-01-05

Family

ID=26040079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000511728A Pending JP2001516732A (ja) 1997-09-18 1998-09-16 置換テトラヒドロナフタリンおよび類似化合物

Country Status (9)

Country Link
US (1) US6586613B1 (enExample)
EP (1) EP1017659B1 (enExample)
JP (1) JP2001516732A (enExample)
AT (1) ATE294152T1 (enExample)
AU (1) AU9744298A (enExample)
ES (1) ES2242302T3 (enExample)
MA (1) MA24643A1 (enExample)
PT (1) PT1017659E (enExample)
WO (1) WO1999014174A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
AU3103800A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
DE19935966A1 (de) * 1999-07-30 2001-02-01 Bayer Ag Verfahren zur Reduktion von Ketoalkoholen
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
KR100759635B1 (ko) 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
DE10148436A1 (de) * 2001-10-01 2003-04-17 Bayer Ag Tetrahydrochinoline
FR2832919B1 (fr) 2001-12-04 2004-02-20 Imv Technologies Seringue d'injection du contenu d'une paillette pour l'insemination artificielle d'un animal ou le transfert embryonnaire
WO2003053359A2 (en) 2001-12-19 2003-07-03 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
CN1596240A (zh) 2001-12-19 2005-03-16 阿特罗吉尼克斯公司 查耳酮衍生物及其治疗疾病的用途
MXPA04006255A (es) 2002-01-17 2004-09-27 Pharmacia Corp Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
AU2003283769A1 (en) 2002-12-20 2004-07-14 Pfizer Products Inc. Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
KR20080008440A (ko) 2003-03-17 2008-01-23 니뽄 다바코 산교 가부시키가이샤 Ｃｅｔｐ 억제제의 약제학적 조성물
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
JP2007501218A (ja) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
KR20070087197A (ko) 2003-09-26 2007-08-27 니뽄 다바코 산교 가부시키가이샤 잔여 리포프로테인 생산 저해 방법
MX2007007188A (es) * 2004-12-18 2007-08-14 Bayer Healthcare Ag Derivados de tetrahidroquinolina sustituidos en 4 con cicloalquilo y su uso como medicamentos.
EP1844078B1 (en) 2005-02-03 2016-09-28 Bend Research, Inc Pharmaceutical compositions with enhanced performance
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
RU2008119687A (ru) 2005-10-21 2009-11-27 Новартис АГ (CH) Комбинации органических соединений
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
AU2009221179A1 (en) * 2008-03-05 2009-09-11 Boehringer Ingelheim International Gmbh Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
US20110245209A1 (en) 2008-12-16 2011-10-06 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
MX2013000359A (es) 2010-07-09 2013-02-11 Ube Industries Compuesto de piridina sustituida.
US9938228B2 (en) 2014-09-09 2018-04-10 Boehringer Ingelheim International Gmbh Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
US5446207A (en) 1993-09-01 1995-08-29 Harbor Branch Oceanographic Institution, Inc. Anti-dyslipidemic agents
HRP970330B1 (en) 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines

Similar Documents

Publication Publication Date Title
JP2003520235A5 (enExample)
JP2001516757A5 (enExample)
JP3316661B2 (ja) 〔（ヒドロキシフェニルアミノ）カルボニル〕ピロール
JP2003532731A5 (enExample)
KR101044494B1 (ko) 치환된 이미다졸 및 농약으로서의 이들의 용도
JP2022533398A5 (enExample)
HUT67276A (en) Stereoselective preparation of substituted piperidines
JP2004535436A5 (enExample)
RU2001124567A (ru) Производные индола и их применение в качестве антагонистов мср-1
JP2002523395A5 (enExample)
JP2002523396A5 (enExample)
WO1998047505A9 (en) Neuropeptide y receptor antagonist
RU2002131886A (ru) Азабициклические карбаматы и их применение в качестве агонистов альфа-7 никотинового ацетилхолинового рецептора
CA2485641A1 (en) Novel condensed imidazole derivatives
JP2002502874A5 (enExample)
JP2011084579A (ja) ソリフェナシン又はその塩の製造法
JP2005526836A5 (enExample)
JP2002518502A5 (enExample)
JP2007510707A5 (enExample)
RU2006144710A (ru) Новые производные циклопента [b] бензофурана и их применение
JP2006525299A (ja) アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用
JP2005517657A5 (enExample)
CA2524898A1 (en) 6-arylmethyl-substituted pyrazolopyrimidines
JP2001524477A5 (enExample)
RU2323211C2 (ru) Новые производные бензимидазола, способы их получения, их применение и содержащая их фармацевтическая композиция